ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Australia Private Bloodwork for TRT Use Approval: Testing Service Announced

Australia's leading telehealth clinic dedicated to TRT testing is now offering a convenient service that allows clients to get blood work done without leaving home.

-- TRT Australia has introduced a telehealth service offering private blood work designed to expedite Testosterone Replacement Therapy (TRT) approval. This approach allows patients to complete necessary blood testing before their consultation, potentially accelerating the approval process by up to 95%.

More information is available at https://trtaustralia.com/

TRT is legal and approved in Australia, but it is regulated and requires a prescription from a licensed doctor. To get approved for TRT, a patient must undergo blood tests to confirm low testosterone levels, and treatment is typically prescribed after consultation with a doctor or a specialist such as an endocrinologist.

“We offer a perfectly legal way of expediting this approval process by making the prerequisite of getting blood work as convenient as possible,” a spokesperson for TRT Australia said. “And as a gesture of good faith, you don’t need to pay us unless you get the green light for TRT treatment.”

Additional information can be found at https://trtaustralia.com/resources/

The service follows a three-step process beginning with comprehensive blood testing to assess hormone levels and overall health. This is followed by a medical consultation examining the patient's medical history and potential causes of low testosterone. Once approved, personalised treatment plans are created and medication is dispatched from Australian pharmacy partners directly to patients' homes.

The clinic provides two options for completing the required blood work: private testing (their recommended method) or through a general practitioner. For the latter, the telehealth service accepts blood tests conducted within the past four months.

The private blood work option is comprehensive, measuring every essential marker such as free and total testosterone, SHBG, E2, FSH/LH, prolactin, progesterone, thyroid function, liver and kidney function, cholesterol profiles, and glucose levels.

Once blood work results are uploaded, TRT Australia's medical team can review them within 24 hours, sometimes even on the same day. This rapid assessment contributes to the accelerated approval process that sets their service apart from traditional hormone therapy pathways.

TRT Australia was formed to enable faster blood testing on behalf of those struggling with low testosterone levels and in need of supplementation. While not a pharmacy, it facilitates access to medical practitioners across Australia who specialise in the diagnosis and treatment of low testosterone.

Those who want to know more or request a test may visit https://trtaustralia.com/

Contact Info:
Name: James Malachowski
Email: Send Email
Organization: TRT Australia
Address: 7–11 The Avenue, Hurstville, NSW 2220, Australia
Phone: +61-483-984-020
Website: https://trtaustralia.com/X

Source: PressCable

Release ID: 89170894

If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.